Market Overview

UPDATE: Morgan Stanley Initiates Coverage On Intuitive Surgical

Share:
Related ISRG
Canaccord On Intuitive Surgical Following Earnings: 'Stay Buyers'
12 Stocks You Should Be Watching Today
Nasdaq Turns Positive; 3 Medicals To Watch; Will Snap Complete A Base? (Investor's Business Daily)

In a report released Wednesday, Morgan Stanley analyst David Lewis initiated coverage on Intuitive Surgical (NASDAQ: ISRG) with a base case of $370. Morgan Stanley previously had an Overweight rating.

Analysts at Morgan Stanley believe Intuitive Surgical's improved procedures will result in a short run investor relief rally, but they don't see proof of inflection. Lewis claimed Intuitive Surgical's ability to manage stock-comp is out of range compared to its peers.

Morgan Stanley is prevented from calling an inflection due to system utilization rates continuing to be in negative territory year-over-year. This indicates underlying demand for new systems, comps uncertainty from its recovery to decline and net system payments decline quarter-over-quarter.

Morgan Stanley's base case of $370 per share was given by a 25x multiple from its 2015 estimate of $14.78.

Latest Ratings for ISRG

DateFirmActionFromTo
Jan 2017Evercore ISI GroupDowngradesBuyHold
Oct 2016Wells FargoInitiates Coverage OnOutperform
Aug 2016Raymond JamesInitiates Coverage onOutperform

View More Analyst Ratings for ISRG
View the Latest Analyst Ratings

Posted-In: David Lewis Morgan StanleyAnalyst Color Initiation Analyst Ratings

 

Related Articles (ISRG)

View Comments and Join the Discussion!